利多卡因在宫颈癌术后尿潴留中的应用

目的 分析利多卡因用于预防宫颈癌行广泛性子宫切除术后尿潴留的疗效.方法 将65例因宫颈癌行广泛性子宫切除术患者按随机数字表法分为两组：治疗组32例,于拔除导尿管后立即予浸润2％利多卡因1 ml的棉球放置尿道口20 min以上再排尿;对照组33例,为常规拔除导尿管的患者.比较两组尿潴留发生情况及药物不良反应.结果 治疗组残余尿量为（53±22）ml,发生尿潴留1例（3.12％,1/32）,对照组分别为（163±32） ml和8例（24.24％,8/33）,两组比较差异有统计学意义（P＜0.05）.结论 利多卡因对于宫颈癌行广泛性子宫切除术后的尿潴留有较好的预防作用,可在临床推广应用.

The application of lidocaine in cervical cancer postoperative urinary retention

Objective To analyze the therapeutic effect of lidocaine in cervical cancer postoperative urinary retention.Methods Sixty-five patients with cervical cancer postoperative urinary retention were divided into two groups by random digits table method：treatment group 32 cases,immediately after the urethral catheter to infiltrate 1 ml of 2% lidocaine cotton ball placed urethral opening more than 20 minutes again urine; control group 33 cases,routine for patients with urethral catheter.The incidence of urinary retention and adverse drug reactions were compared between two groups.Results Treatment group residual urine volume was（53 ± 22） ml,1 case（3.12%,1/32） of urinary retention,control group was （163 ± 32） ml and 8 cases （24.24%,8/33）,there was significant difference （P 〈 0.05）.Conclusion Lidocaine for cervical cancer postoperative urinary retention has good prevention effect,can be popularized in clinical application.